Max Zinter
Impact in
-
- Nanoparticle-Based Drug Delivery
-
- Glioma Diagnosis and Treatment
- Virus-based gene therapy research
Papers in
- Oncology 2
- Cytokine Signaling Pathways and Interactions 1
- Cancer Immunotherapy and Biomarkers 1
- Co-authors
- Bakhos A. Tannous (6 shared papers)Litia Carvalho (4 shared papers)Ralph Weissleder (2 shared papers)E. Antonio Chiocca (2 shared papers)Hasan Akbaba (1 shared paper)Gülşah Erel‐Akbaba (1 shared paper)Tian Tian (1 shared paper)Ayşe Gülten Kantarcı (1 shared paper)
- Journals
- Cell Death Discovery (1 paper)ACS Nano (1 paper)Molecular Neurobiology (1 paper)Cell Reports (1 paper)Molecular Therapy — Methods & Clinical Development (1 paper)
- Partner nations
- United StatesMalaysiaBrazil
In The Last Decade
Max Zinter
6 papers receiving 278 citations
Peers
Comparison fields: 5 of 53
- Biomaterials 83
- Genetics 32
- Cancer Research 43
- Biomedical Engineering 106
- Developmental Neuroscience 8
Countries citing papers authored by Max Zinter
This map shows the geographic impact of Max Zinter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Zinter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Zinter more than expected).
Fields of papers citing papers by Max Zinter
This network shows the impact of papers produced by Max Zinter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Zinter. The network helps show where Max Zinter may publish in the future.
Co-authors
The 25 scholars most cited alongside Max Zinter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 176 | |
| 2 | 2019 | 34 | |
| 3 | 2019 | 22 | |
| 4 | 2018 | 22 | |
| 5 | 2019 | 21 | |
| 6 | 2024 | 3 |
About Max Zinter
Max Zinter is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Pathology and Forensic Medicine, having authored 6 papers that have together received 278 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (2 papers), Cancer Mechanisms and Therapy (1 paper), Nanoplatforms for cancer theranostics (1 paper), Nanoparticle-Based Drug Delivery (1 paper), Cytokine Signaling Pathways and Interactions (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Immunotherapy and Immune Responses (1 paper) and Tuberous Sclerosis Complex Research (1 paper). The work is most often cited by research in Biomaterials (83 citations), Genetics (32 citations), Cancer Research (43 citations), Biomedical Engineering (106 citations) and Developmental Neuroscience (8 citations). Max Zinter has collaborated with scholars based in United States, Malaysia and Brazil. Frequent co-authors include Bakhos A. Tannous, Litia Carvalho, Ralph Weissleder, E. Antonio Chiocca, Hasan Akbaba, Gülşah Erel‐Akbaba, Tian Tian, Ayşe Gülten Kantarcı, Pierre J. Obeid and Pike-See Cheah. Their work appears in journals such as Cell Death Discovery, ACS Nano, Molecular Neurobiology, Cell Reports and Molecular Therapy — Methods & Clinical Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.